vs
Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and Ralliant Corp (RAL). Click either name above to swap in a different company.
Ralliant Corp is the larger business by last-quarter revenue ($529.1M vs $382.2M, roughly 1.4× LifeStance Health Group, Inc.). Ralliant Corp runs the higher net margin — 7.5% vs 3.1%, a 4.5% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -0.5%). Ralliant Corp produced more free cash flow last quarter ($126.6M vs $46.6M).
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
LFST vs RAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $382.2M | $529.1M |
| Net Profit | $11.7M | $39.9M |
| Gross Margin | — | 50.8% |
| Operating Margin | 4.7% | 9.8% |
| Net Margin | 3.1% | 7.5% |
| Revenue YoY | 17.4% | -0.5% |
| Net Profit YoY | 264.1% | -56.1% |
| EPS (diluted) | — | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $382.2M | — | ||
| Q3 25 | $363.8M | $529.1M | ||
| Q2 25 | $345.3M | $503.3M | ||
| Q1 25 | $333.0M | — | ||
| Q4 24 | $325.5M | — | ||
| Q3 24 | $312.7M | $531.7M | ||
| Q2 24 | $312.3M | $533.7M | ||
| Q1 24 | $300.4M | — |
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.1M | $39.9M | ||
| Q2 25 | $-3.8M | $47.6M | ||
| Q1 25 | $709.0K | — | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-6.0M | $90.9M | ||
| Q2 24 | $-23.3M | $64.8M | ||
| Q1 24 | $-21.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 50.8% | ||
| Q2 25 | — | 49.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 52.6% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | — |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 2.0% | 9.8% | ||
| Q2 25 | -0.9% | 11.7% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | 20.9% | ||
| Q2 24 | -5.1% | 19.7% | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 0.3% | 7.5% | ||
| Q2 25 | -1.1% | 9.5% | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -1.9% | 17.1% | ||
| Q2 24 | -7.5% | 12.1% | ||
| Q1 24 | -7.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.35 | ||
| Q2 25 | — | $0.42 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0.81 | ||
| Q2 24 | — | $0.57 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $248.6M | $264.2M |
| Total DebtLower is stronger | $282.8M | $1.1B |
| Stockholders' EquityBook value | $1.5B | $3.0B |
| Total Assets | $2.2B | $5.3B |
| Debt / EquityLower = less leverage | 0.19× | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $248.6M | — | ||
| Q3 25 | $203.9M | $264.2M | ||
| Q2 25 | $188.9M | $198.6M | ||
| Q1 25 | $134.3M | — | ||
| Q4 24 | $154.6M | — | ||
| Q3 24 | $102.6M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $49.5M | — |
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | $1.1B | ||
| Q2 25 | $286.4M | $1.1B | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $3.0B | ||
| Q2 25 | $1.5B | $3.0B | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $4.0B | ||
| Q2 24 | $1.4B | $4.0B | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.1B | $5.3B | ||
| Q2 25 | $2.1B | $5.2B | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.1B | — |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | 0.39× | ||
| Q2 25 | 0.19× | 0.38× | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $57.6M | $138.6M |
| Free Cash FlowOCF − Capex | $46.6M | $126.6M |
| FCF MarginFCF / Revenue | 12.2% | 23.9% |
| Capex IntensityCapex / Revenue | 2.9% | 2.3% |
| Cash ConversionOCF / Net Profit | 4.93× | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | $110.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | — | ||
| Q3 25 | $27.3M | $138.6M | ||
| Q2 25 | $64.4M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $62.3M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $-21.8M | — |
| Q4 25 | $46.6M | — | ||
| Q3 25 | $17.0M | $126.6M | ||
| Q2 25 | $56.6M | — | ||
| Q1 25 | $-10.3M | — | ||
| Q4 24 | $56.0M | — | ||
| Q3 24 | $17.7M | — | ||
| Q2 24 | $39.0M | — | ||
| Q1 24 | $-26.9M | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 4.7% | 23.9% | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | -9.0% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.8% | 2.3% | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | 3.47× | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFST
Segment breakdown not available.
RAL
| Industrial Manufacturing | $111.1M | 21% |
| Defense And Space | $93.6M | 18% |
| Diversified Electronics | $91.0M | 17% |
| Test And Measurement | $76.8M | 15% |
| Communications | $60.7M | 11% |
| Semiconductors | $51.4M | 10% |
| Other Direct End Markets | $44.4M | 8% |
